2.4.0.6 Html 68 160 1 false 17 0 false 4 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.chelseatherapeutics.com/role/DocumentDocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION true false R2.htm 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.chelseatherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.chelseatherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://www.chelseatherapeutics.com/role/StatementCondensedConsolidatedStatementOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY false false R6.htm 006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY [Parenthetical] false false R7.htm 007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.chelseatherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] Sheet http://www.chelseatherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] false false R9.htm 009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NATURE OF OPERATIONS Sheet http://www.chelseatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAndNatureOfOperations SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NATURE OF OPERATIONS false false R10.htm 010 - Disclosure - SHORT-TERM INVESTMENTS Sheet http://www.chelseatherapeutics.com/role/DisclosureShortTermInvestments SHORT-TERM INVESTMENTS false false R11.htm 011 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.chelseatherapeutics.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS false false R12.htm 012 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.chelseatherapeutics.com/role/DisclosureStockBasedCompensation STOCK-BASED COMPENSATION false false R13.htm 013 - Disclosure - LOSS PER SHARE Sheet http://www.chelseatherapeutics.com/role/DisclosureLossPerShare LOSS PER SHARE false false R14.htm 014 - Disclosure - EXERCISE OF COMMON STOCK WARRANTS Sheet http://www.chelseatherapeutics.com/role/DisclosureExerciseOfCommonStockWarrants EXERCISE OF COMMON STOCK WARRANTS false false R15.htm 015 - Disclosure - REGISTERED DIRECT SALE OF COMMON STOCK Sheet http://www.chelseatherapeutics.com/role/DisclosureRegisteredDirectSaleOfCommonStock REGISTERED DIRECT SALE OF COMMON STOCK false false R16.htm 016 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.chelseatherapeutics.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R17.htm 017 - Disclosure - RESTRUCTURING Sheet http://www.chelseatherapeutics.com/role/Restructuring RESTRUCTURING false false R18.htm 018 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.chelseatherapeutics.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R19.htm 019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NATURE OF OPERATIONS (Policies) Sheet http://www.chelseatherapeutics.com/role/SummaryOfSignificantAccountingPoliciesAndNatureOfOperationsPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NATURE OF OPERATIONS (Policies) false false R20.htm 020 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.chelseatherapeutics.com/role/StockBasedCompensationTables STOCK-BASED COMPENSATION (Tables) false false R21.htm 021 - Disclosure - RESTRUCTURING (Tables) Sheet http://www.chelseatherapeutics.com/role/RestructuringTables RESTRUCTURING (Tables) false false R22.htm 022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NATURE OF OPERATIONS (Details Textual) Sheet http://www.chelseatherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESANDNATUREOFOPERATIONSDetailsTextual SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NATURE OF OPERATIONS (Details Textual) false false R23.htm 023 - Disclosure - SHORT-TERM INVESTMENTS (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Shortterminvestmentsdetailstextual SHORT-TERM INVESTMENTS (Details Textual) false false R24.htm 024 - Disclosure - FAIR VALUE MEASUREMENTS (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Fairvaluemeasurementsdetailstextual FAIR VALUE MEASUREMENTS (Details Textual) false false R25.htm 025 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://www.chelseatherapeutics.com/role/StockBasedCompensationDetails STOCK-BASED COMPENSATION (Details) false false R26.htm 026 - Disclosure - STOCK-BASED COMPENSATION (Details 1) Sheet http://www.chelseatherapeutics.com/role/StockBasedCompensationDetails1 STOCK-BASED COMPENSATION (Details 1) false false R27.htm 027 - Disclosure - STOCK-BASED COMPENSATION (Details 2) Sheet http://www.chelseatherapeutics.com/role/StockBasedCompensationDetails2 STOCK-BASED COMPENSATION (Details 2) false false R28.htm 028 - Disclosure - STOCK-BASED COMPENSATION (Details 3) Sheet http://www.chelseatherapeutics.com/role/StockBasedCompensationDetails3 STOCK-BASED COMPENSATION (Details 3) false false R29.htm 029 - Disclosure - STOCK-BASED COMPENSATION (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Stockbasedcompensationdetailstextual STOCK-BASED COMPENSATION (Details Textual) false false R30.htm 030 - Disclosure - LOSS PER SHARE (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Losspersharedetailstextual LOSS PER SHARE (Details Textual) false false R31.htm 031 - Disclosure - EXERCISE OF COMMON STOCK WARRANTS (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Exerciseofcommonstockwarrantsdetailstextual EXERCISE OF COMMON STOCK WARRANTS (Details Textual) false false R32.htm 032 - Disclosure - REGISTERED DIRECT SALE OF COMMON STOCK (Details Textual) Sheet http://www.chelseatherapeutics.com/role/Registereddirectsaleofcommonstockdetailstextual REGISTERED DIRECT SALE OF COMMON STOCK (Details Textual) false false R33.htm 033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Textual) Sheet http://www.chelseatherapeutics.com/role/COMMITMENTSANDCONTINGENCIESDetailsTextual COMMITMENTS AND CONTINGENCIES (Details Textual) false false R34.htm 034 - Disclosure - RESTRUCTURING (Details) Sheet http://www.chelseatherapeutics.com/role/RestructuringDetails RESTRUCTURING (Details) false false R35.htm 035 - Disclosure - RESTRUCTURING (Details Textual) Sheet http://www.chelseatherapeutics.com/role/RestructuringDetailsTexual RESTRUCTURING (Details Textual) false false All Reports Book All Reports Element us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost had a mix of decimals attribute values: -5 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate had a mix of decimals attribute values: 2 4. Element us-gaap_StockIssuedDuringPeriodValueNewIssues had a mix of decimals attribute values: -5 0. Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Apr. 02, 2002' Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: Removing column 'Dec. 31, 2002' Process Flow-Through: 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY [Parenthetical] Process Flow-Through: 007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Parenthetical] chtp-20120930.xml chtp-20120930.xsd chtp-20120930_cal.xml chtp-20120930_def.xml chtp-20120930_lab.xml chtp-20120930_pre.xml true true